Bard Associates’s M-tron Industries MPTI Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$4.42M Sell
44,578
-40,940
-48% -$3.26M 0.98% 34
2026
Q1
$5.72M Sell
85,518
-611
-0.7% -$39K 1.43% 19
2025
Q4
$4.58M Sell
86,129
-908
-1% -$48K 1.18% 31
2025
Q3
$4.83M Sell
87,037
-50
-0.1% -$2.24K 1.28% 28
2025
Q2
$3.66M Sell
87,087
-1,500
-2% -$72.2K 1.18% 30
2025
Q1
$3.95M Sell
88,587
-350
-0.4% -$16.6K 1.47% 17
2024
Q4
$4.31M Sell
88,937
-250
-0.3% -$13.7K 1.46% 18
2024
Q3
$3.72M Sell
89,187
-275
-0.3% -$9.54K 1.27% 19
2024
Q2
$3.15M Sell
89,462
-200
-0.2% -$6.11K 1.21% 22
2024
Q1
$2.69M Sell
89,662
-6,020
-6% -$226K 0.97% 36
2023
Q4
$3.42M Sell
95,682
-21,392
-18% -$636K 1.3% 19
2023
Q3
$2.07M Buy
117,074
+1,018
+0.9% +$15.2K 0.86% 45
2023
Q2
$1.29M Sell
116,056
-465
-0.4% -$5.52K 0.5% 69
2023
Q1
$1.25M Buy
116,521
+50
+0% +$508 0.52% 63
2022
Q4
$1.02M Buy
+116,471
New +$1.2M 0.44% 78

Other funds holding MPTI

Bard Associates's MPTI Position: Q2 2026 in Review

Bard Associates reduced its M-tron Industries (MPTI) stake by 48% in Q2 2026, selling an estimated $3.26M and leaving 44,578 shares worth $4.42M. The position accounts for 0.98% of the portfolio, ranked #34.

Bard Associates first reported a position in MPTI in Q4 2022 and has held it in 15 quarters since. The position peaked at $5.72M in Q1 2026. 118 funds tracked by Wall St. Rank hold MPTI as of Q2 2026.

  • Bard Associates held 44,578 shares of M-tron Industries worth $4.42M as of Q2 2026.
  • Bard Associates sold 40,940 M-tron Industries shares in Q2 2026, an estimated $3.26M.
  • M-tron Industries made up 0.98% of Bard Associates's portfolio in Q2 2026, its #34 holding.
  • Bard Associates first reported a position in M-tron Industries in Q4 2022 and has held it in 15 quarters since.
  • Bard Associates's M-tron Industries position peaked at $5.72M in Q1 2026.
  • 118 funds tracked by Wall St. Rank held M-tron Industries as of Q2 2026.

Based on Bard Associates's 13F filing for Q2 2026, filed 12 Aug 2026.